Mon panier

PTK7

PTK7 Informations sur la molécule

Nom anglaisProtein-tyrosine kinase 7Nombre de médicaments commercialisés0
Nombre de médicaments cliniques8Alias de la cibleColon carcinoma kinase 4,Inactive tyrosine-protein kinase 7,Tyrosine-protein kinase-like 7,CCK-4,PTK7,Protein Tyrosine Kinase 7 (Inactive),Pseudo Tyrosine Kinase Receptor 7,PTK7 Protein Tyrosine Kinase 7,CCK4,Protein-Tyrosine Kinase 7,Protein Tyrosine Kinase 7
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisProtein-tyrosine kinase 7
Alias de la cibleColon carcinoma kinase 4,Inactive tyrosine-protein kinase 7,Tyrosine-protein kinase-like 7,CCK-4,PTK7,Protein Tyrosine Kinase 7 (Inactive),Pseudo Tyrosine Kinase Receptor 7,PTK7 Protein Tyrosine Kinase 7,CCK4,Protein-Tyrosine Kinase 7,Protein Tyrosine Kinase 7
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques8
Phase de R&D la plus avancéePhase 2 Clinical

PTK7 Liste de produits

  • Attribut

    Protein (11)Cell (1)Antibody (1)

  • Bibliothèque de produits

    En ligne (13)

  • Espèces

    Human (5)Mouse (3)Rabbit (2)Cynomolgus / Rhesus macaque (1)Rat (2)

  • Étiquette

    His Tag (5)His Tag & Avi Tag (2)Fc Tag (3)Fc Tag & Avi Tag (1)- (2)

  • Marqueur

    Unconjugated (9)Biotin-labeled (3)- (1)

PTK7Contexte de la molécule

PTK7, highly expressed in lung, liver, pancreas, kidney, placenta and melanocytes. Weakly expressed in thyroid gland, ovary, brain, heart and skeletal muscle. Also expressed in erythroleukemia cells. Inactive tyrosine kinase involved in Wnt signaling pathway. Component of both the non-canonical (also known as the Wnt/planar cell polarity signaling) and the canonical Wnt signaling pathway. Functions in cell adhesion, cell migration, cell polarity, proliferation, actin cytoskeleton reorganization and apoptosis. Has a role in embryogenesis, epithelial tissue organization and angiogenesis.

PTK7Alias de la molécule

PTK7,CCK4,CCK-4,Tyrosine-protein kinase-like 7,Protein-tyrosine kinase 7,Protein-tyrosine kinase 7

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
SKB-518SKB518; SKB-518Phase 2 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co LtdGenital Neoplasms, Female; Lung Neoplasms; Neoplasms; Solid tumours
Details
Cofetuzumab PelidotinPF-06647020; PF-6647020; PTK7-ADC; PF-06523435; PF-7020; hu-24; ABBV-647; Anti-PTK7 ADC; h6M24-vc0101Phase 1 ClinicalAbbvie Inc, Stemcentrx IncCarcinoma, Non-Small-Cell Lung; Neoplasms
Details
68Ga-Sgc8Phase 1 ClinicalThe First Affiliated Hospital of Air Force Medical UniversityColorectal Neoplasms
Details
PTK7 ADC (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And CompanyNeoplasms
Details
KIVU-107KIVU-107Phase 1 ClinicalKivu Bioscience IncSolid tumours
Details
LY-4175408LY4175408; LY-4175408Phase 1 ClinicalEli Lilly And CompanyCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms
Details
IDE-034BCG034; IDE034; IDE-034Phase 1 ClinicalColorectal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Solid tumours
Details
DAY-301DAY301; DAY-301; MTX-13; CB-002Phase 1 ClinicalShanghai Mycos Biomedicine Co LtdSolid tumours
Details

Avis sur les produits

  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques